The Impact of Omega-3 Fatty Acid Use on the Risk of Atrial Fibrillation in Patients with Cardiovascular Disease
Brian J. Barnes, Patricia A. Howard, Scott Solomon, Warren Chen, James L. Vacek
DOI: 10.4236/ijcm.2011.21006   PDF    HTML     5,710 Downloads   9,552 Views   Citations


Fish oils containing omega-3 fatty acids (OM3FA) are widely prescribed in the management of dyslipidemia. An asso-ciation between OM3FA and reduced risk of atrial fibrillation (AF) has been proposed. We examined the impact of OM3FA exposure on the risk of developing AF in patients with cardiovascular disease. Data was obtained from elec-tronic medical records of patients seen by our cardiology service between 2005 and 2007. Patients were excluded if AF developed prior to, or on the day of, OM3FA exposure. A total of 11,360 subjects were eligible for analyses. Subjects exposed to OM3FA were at higher risk for AF. Nearly all AF risk factors were significantly more prevalent in the OM3FA exposed group. As expected, those prescribed OM3FA were also more likely to be prescribed statins, ACE in-hibitors, aspirin, and beta blockers. AF occurred in 8.5% (221/2600) of OM3FA exposed subjects and 23.5% (2054/8760) of those not exposed. After controlling for AF risk factors, OM3FA exposed subjects were 74% less likely to develop AF than those not exposed to OM3FA (odds ratio 0.26, 95%CI 0.22-0.30, p < 0.0001). After controlling for risk factors for AF, OM3FA use is significantly associated with a reduced risk for AF in patients with cardiovascular disease. Potential mechanisms which may explain the ability of OM3FAs to reduce AF include its anti-inflammatory and anti-arrhythmic properties. The optimal dose of OM3FA to prevent AF is unknown and warrants prospective as-sessment in a randomized controlled trial of OM3FAs powered to detect significant differences in AF.

Share and Cite:

B. Barnes, P. Howard, S. Solomon, W. Chen and J. Vacek, "The Impact of Omega-3 Fatty Acid Use on the Risk of Atrial Fibrillation in Patients with Cardiovascular Disease," International Journal of Clinical Medicine, Vol. 2 No. 1, 2011, pp. 23-27. doi: 10.4236/ijcm.2011.21006.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] D. Mozaffarian, B. M. Psaty, E. B. Rimm, R. N. Lemaitre, G. L. Burke, M. F. Lyles, D. Lefkowitz and D. S. Siscovick, “Fish Intake and Risk of Incident Atrial Fibrillation,” Circulation, Vol. 110, No. 1, July 2004, pp. 368- 373. doi:10.1161/01.CIR.0000138154.00779.A5
[2] J. W. H. Fung, J. E.Sanderson, G. W. K. Yip, Q. Zhang, C. M. Yu. Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and echocardiographic study. Journal of Cardiac Failure, Vol. 13, No. 8, October 2007, pp. 649-655. doi:10.1016/j.cardfail.2007.04.014
[3] M. B. Covington, “Omega-3 Fatty Acids,” American Family Physician, Vol. 70, No. 1, July 2004, pp. 133-140.
[4] Dietary Supplementation with n-3 Polyunsaturated Fatty Acids and Vitamin E after Myocardial Infarction: Results of the GISSI-Precenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico, Lancet, Vol. 354, August 1999, pp. 447-455.
[5] L. Calò, L. Bianconi, F. Colivicchi, F. Lamberti, M. L. Loricchio, E. de Ruvo, et al. “N-3 Fatty Acids for the Prevention of Atrial Fibrillation after Coronary Bypass Surgery,” Journal of the American College of Cardiology, Vol. 45, No. 10, May 2005, pp. 1723-1728. doi:10.1016/j.jacc.2005.02.079
[6] A. Macchia, S. Monte, F. Pellegrini, M. Romero, D. Ferrante, H. Doval, A. D’Ettorre, A. P. Maggioni and G. Tognoni, “Omega-3 Fatty Acid Supplementation Reduces One-Year Risk of Atrial Fibrillation in Patients Hospitalized with Myocardial Infarction,” European Journal of Clinical Pharmacology, Vol. 64, No. 4, April 2008, pp. 627-634. doi:10.1007/s00228-008-0464-z
[7] J. X. Kang, Y. F. Xiao and A. Leaf, “Free, Long-Chain, Polyunsaturated Fatty Acids Reduce Membrane Electrical Excitability in Neonatal Rat Cardiac Myocytes,” Proceedings of National Academy Science USA, Vol. 92, No. 9, April 1995, pp. 3997-4001. doi:10.1073/pnas.92.9.3997
[8] J. F. Sarrazin, G. Comeau, P. Daleau, J. Kingma, I. Plante, D. Fournier and F. Molin, “Reduced Incidence of Vagally Induced Atrial Fibrillation and Expression Levels of Connexins by N-3 Polyunsaturated Fatty Acids in Dogs,” Journal of the American College of Cardiology, Vol. 50, No 15, October 2007, pp. 1505-1512. doi:10.1016/j.jacc.2007.05.046
[9] G. Laurent, G. Moe, X. Hu, B. Holub, H. Leong-Poi, J. Trogadis, K. Connelly, D. Courtman, B. H. Strauss, P. Dorian, “Long Chain n-3 Polyunsaturated Fatty Acids Reduce Atrial Vulnerability in a Novel Canine Pacing Model,” Cardiovasc Research, Vol. 77, No. 1, January 2008, pp. 89-97. doi:10.1093/cvr/cvm024
[10] E. Guallar, A. Aro, F. J. Jiménez, J. M. Martín-Moreno, I. Salminen, P. van't Veer, A. F. Kardinaal, J. Gómez-Aracena, B. C. Martin, L. Kohlmeier, J. D. Kark, V. P. Mazaev, J. Ringstad, J. Guillén, R. A. Riemersma, J. K. Huttunen, M. Thamm, F. J. Kok, “Omega-3 Fatty Acids in Adipose Tissue and Risk of Myocardial Infarction: The EURAMIC Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 19, No. 4, January 1999, pp. 1111-1118.
[11] S. Grimsgaard, K. H. Bonaa, J. B. Hansen and E. S. Myhre, “Effects of Highly Purified Eicosapentaenoic Acid and Docosahexaenoic Acid on Hemodynamics in Humans,” American Journal of Clinical Nutrition, Vol. 68, No. 1, July1998, pp. 52-59.
[12] I. Savelieva and J. Camm, “Statins and Polyunsaturated Fatty Acids for Treatment of Atrial Fibrillation,” Nature Reviews Cardiology, Vol. 5, No. 1, January 2008, pp 30-41.
[13] L. Demaison, J. Blet, J. P. Sergiel, S. Gregoire and D. Argaud, “Effect of Dietary Polyunsaturated Fatty Acids on Contractile Function of Hearts Isolated from Sedentary and Trained Rats,” Reproduction Nutrition Development, Vol. 40, No. 2, March-April 2000, pp.113-125. doi:10.1051/rnd:2000124
[14] D. Von Au, M. Brandle, H. Rupp and R. Jacob, “Influence of Diet Rich in Fish Oil on Blood Pressure, Body Weight and Cardiac Hypertrophy in Spontaneously Hypertensive Rats,” European Journal of Applied Physiology and Occupational Physiology, Vol. 58, No. 1, January 1988, pp. 97-99.
[15] S. Pepe and P. McLennan, “Cardiac Membrane Fatty Acid Composition Modulates Myocardial Oxygen Consumption and Postischemic Recovery of Contractile Function,” Circulation, Vol. 105, No. 5, May 2002, pp. 2303-2308. doi:10.1161/01.CIR.0000015604.88808.74
[16] D. Mozaffarian, J. S. Gottdiener and D. S. Siscovick, “Intake of Tuna or Other Broiled or Baked Fish Versus Fried Fish and Cardiac Structure, Function, and Hemodynamics,” The American Journal of Cardiology, Vol. 97, No. 2, January 2006, pp. 216-222.
[17] D. Mozaffarian, R. Prineas, P. K. Stein and D. S. Siscovick, “Dietary Fish and n-3 Fatty Acid Intake and Cardiac Electrocardiographic Parameters in Humans,” Journal of the American College of Cardiology, Vol. 48, No. 3, August 2006, pp. 478-484. doi:10.1016/j.amjcard.2005.08.025
[18] E. M. Balk, A. H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew and J. Lau, “Effects of Omega-3 Fatty Acids on Serum Markers of Cardiovascular Disease Risk: A Systemic Review,” Atherosclerosis, Vol. 189, No. 1, November 2006, pp. 19-30. doi:10.1016/j.atherosclerosis.2006.02.012
[19] W. S. Harris, “n-3 Fatty Acids and Serum Lipoproteins: Human Studies,” American Journal of Clinical Nutrition, Vol. 65, No. 5, May 1997, pp. s1645-s1654.
[20] R. G. Anand, M. Alkadri, C. J. Lavie and R. V. Milani, “The Role of Fish Oil in Arrhythmia Prevention,” Journal of Cardiopulmonary Rehabilitation and Prevention, Vol. 28, No. 2, March-April 2008, pp. 92-98.
[21] J. W. M. Cheng and F. Santoni, “Omega-3 Fatty Acid: A Role in the Management of Cardiac Arrhythmias?” Journal of Alternative and Complementary Medicine, Vol. 14, No. 8, 2008, pp. 1-10.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.